Sight Sciences Defeats Invalidity Challenges Filed By Alcon and Ivantis In The U.S. Patent Office
30 mars 2023 08h00 HE
|
Sight Sciences, Inc.
MENLO PARK, Calif., March 30, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences,” or the “Company”), an eyecare technology company focused on creating innovative...
Sight Sciences Reports Fourth Quarter and Full Year 2022 Financial Results
13 mars 2023 16h05 HE
|
Sight Sciences, Inc.
MENLO PARK, Calif., March 13, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences,” or the “Company”), an eyecare technology company focused on creating innovative...
Sight Sciences Launches the Ergo-Series of the OMNI® Surgical System
09 mars 2023 08h30 HE
|
Sight Sciences, Inc.
MENLO PARK, Calif., March 09, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative technology that...
Sight Sciences to Report Fourth Quarter and Full Year 2022 Financial Results on March 13, 2023
23 févr. 2023 16h05 HE
|
Sight Sciences, Inc.
MENLO PARK, Calif., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and...
Sight Sciences to Present at the Upcoming Citi 2023 Healthcare Services, Medtech, Tools & HCIT Conference
22 févr. 2023 16h05 HE
|
Sight Sciences, Inc.
MENLO PARK, Calif., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and...
Sight Sciences Announces 1,000th TearCare® Customer Installation
26 janv. 2023 08h30 HE
|
Sight Sciences, Inc.
MENLO PARK, Calif., Jan. 26, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”) an eyecare technology company focused on creating innovative solutions...
Sight Sciences Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Financial Results
09 janv. 2023 16h20 HE
|
Sight Sciences, Inc.
MENLO PARK, Calif., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on creating innovative solutions...
Improvements in Signs and Symptoms of Dry Eye Disease From a Single TearCare® Treatment Sustained Through 12 Months
08 déc. 2022 08h30 HE
|
Sight Sciences, Inc.
DATA PRESENTED AT THE 2022 AMERICAN ACADEMY OF OPTOMETRY MEETINGMEIBOMIAN GLAND FUNCTION IMPROVES BY 63% AND DRY EYE SYMPTOMS REDUCED BY 44% THROUGH 12 MONTHS MENLO PARK, Calif., Dec. 08, 2022 ...
Sight Sciences to Present at the Upcoming Piper Sandler 34th Annual Healthcare Conference
22 nov. 2022 08h30 HE
|
Sight Sciences, Inc.
MENLO PARK, Calif., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and...
Sight Sciences Reports Third Quarter 2022 Financial Results
10 nov. 2022 16h05 HE
|
Sight Sciences, Inc.
MENLO PARK, Calif., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and...